A study in Germany showed that e-cigarettes are significantly effective in quitting smoking, which is consistent with previous research results of scientific research institutions in the United States, Britain, Australia, and other countries. Separately, a US study showed that vaping does not increase the risk of respiratory symptoms.
The first is a recent German study on whether e-cigarettes can effectively assist in smoking cessation. The study, published in the German medical journal Deutsches Ärzteblatt, tracked 2,740 smokers aged 14 to 96 through big data. The results of the study showed that the smoking cessation effect of e-cigarettes is much higher than that of other methods.
The second study, conducted by 19 researchers of different nationalities and published in the journal Addiction, covered 3,516 smokers in Australia, the United Kingdom, Canada, and the United States. The authors pointed out in the article that among all study participants, the possibility of quitting smoking with e-cigarettes was 7 times that of those who did not try e-cigarettes.
In fact, many national scientific research institutions have confirmed the effectiveness of e-cigarettes for smoking cessation. As early as 2016, a British study confirmed its higher smoking cessation effectiveness, and three years later, Public Health England reported that its success rate of smoking cessation is between 59.7% and 74%, the highest among all tobacco alternatives.
American researchers also came to the same conclusion, the success rate of smoking cessation was 65.1%. In Australia, researchers mentioned that quitting smoking with e-cigarettes has an average success rate of 96 percent compared to quitting without assistance.
In addition, 22 researchers from several universities and research centers in the United States conducted a new study on the relationship between smoking and respiratory symptoms in adults. To this end, they recruited 16,295 adults in the Population Assessment of Tobacco and Health (PATH) Survey jointly conducted by the National Institutes of Health and the US FDA as research objects.
They grouped people who used different product types (cigarettes, cigars, hookahs, e-cigarettes, etc.). The conclusions drawn through data research show that, except for e-cigarettes, people who use all types of products, including cigarettes, have a higher risk of respiratory symptoms. In most cases, the group of people who exclusively use Jomotech e-cigarettes does not lead to an increased respiratory risk.